Skip to main content
Watch Insiders
Market intelligence
MYGNHealthcare

Myriad Genetics, Inc. insider activity

In the last 90 days, 1 corporate insider purchased $27,638 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$27,638
Corporate buyers
1
Latest transaction
Jun 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 8, 2026Rashmi KumarCorporate insiderSale15,000$4.46$66,843
May 14, 2026Paul BisaroCorporate insiderOpen Market Purchase7,500$3.69$27,638